Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Ben Shimol

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Diabetes Research and Clinical Practice|December 21, 2020
Characterization of hyperglycemia in patients receiving immune checkpoint inhibitors: Beyond autoimmune insulin-dependent diabetesAmanda Leiter, Emily Carroll, Danielle Brooks, et al.
International Journal of Environmental Research and Public Health|June 2, 2021
The Utility of 18FDG-PET/CT in Diagnosing Fever of Unknown Origin: The Experience of a Large Tertiary Medical CenterHussein Mahajna, Keren Vaknin, Jennifer Ben Shimol, et al.
European Journal of Endocrinology|September 23, 2021
Metabolic disease and adverse events from immune checkpoint inhibitorsAmanda Leiter, Emily Carroll, Sonia De Alwis, et al.
Cancer Treatment and Research Communications|October 13, 2020
Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockadeKunal K Sindhu, Amanda Leiter, Erin Moshier, et al.
Rheumatology (Oxford, England)|October 12, 2022
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by regionAlain Lescoat, Dörte Huscher, Nils Schoof, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Diabetes Research and Clinical Practice|December 21, 2020
Characterization of hyperglycemia in patients receiving immune checkpoint inhibitors: Beyond autoimmune insulin-dependent diabetesAmanda Leiter, Emily Carroll, Danielle Brooks, et al.
International Journal of Environmental Research and Public Health|June 2, 2021
The Utility of 18FDG-PET/CT in Diagnosing Fever of Unknown Origin: The Experience of a Large Tertiary Medical CenterHussein Mahajna, Keren Vaknin, Jennifer Ben Shimol, et al.
European Journal of Endocrinology|September 23, 2021
Metabolic disease and adverse events from immune checkpoint inhibitorsAmanda Leiter, Emily Carroll, Sonia De Alwis, et al.
Cancer Treatment and Research Communications|October 13, 2020
Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockadeKunal K Sindhu, Amanda Leiter, Erin Moshier, et al.
Rheumatology (Oxford, England)|October 12, 2022
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by regionAlain Lescoat, Dörte Huscher, Nils Schoof, et al.
Pageof 2